Literature DB >> 24639981

The epidemiological aspects of tuberculosis in Hamadan Province during 2005-11.

Salman Khazaei1, Ghodratollah Roshanaei1, Mohammad Saatchi1, Shahab Rezaeian2, Ali Zahiri3, Seyyed Jalal Bathaei3.   

Abstract

BACKGROUND: Epidemiological information on tuberculosis (TB) is required to plan control and prevention strategies and to inform service delivery systems. The aim of present study was to determine the epidemiological status of TB in Hamadan Province covering a seven-year period.
METHODS: In this cross-sectional study all registered TB patients suffering from any form of smear-positive, smear-negative or extra pulmonary from 2005 to 2011 were assessed. Age-adjusted incidence trend was studied. The Cochran-Armitage (C-A) test was used for testing the trends over time.
RESULTS: The mean age of TB patients was 57.0 (±21.1), 49.9% were males, 52.8% were aged 61 years or older and 39.7% were rural residents. Previous history of jailed was present in 13 (2.2%) patients and 12 (2.0%) were HIV positive. From all TB patients, 60.8% were smear-positive, 87.6% were new cases, and 87.3% of smear-positive patients were cured cases. Also, 23.6% patients had history of hospitalization for TB. More than half (55.4%) of TB patients were reported by public health system. Age-adjusted incidence rates of all TB cases during 2005-11 was 3.4, 3.2, 3.6, 4.7, 3.3, 4.4 and 7.3 in 100,000 respectively (C-A trend test, P< 0.001).
CONCLUSION: Although, the incidence rate of TB in Hamadan Province is lower than country's average, increasing trend of TB incidence is not concordant with its decreasing trend in Iran. An epidemiological study is required to evaluate risk factors associated with TB to identify ways to decrease the prevalence of TB.

Entities:  

Keywords:  Epidemiology; Incidence; Iran; Tuberculosis (TB)

Year:  2014        PMID: 24639981      PMCID: PMC3952540          DOI: 10.15171/ijhpm.2014.18

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN: 2322-5939


  18 in total

1.  Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa.

Authors:  C Lienhardt; K Fielding; J S Sillah; B Bah; P Gustafson; D Warndorff; M Palayew; I Lisse; S Donkor; S Diallo; K Manneh; R Adegbola; P Aaby; O Bah-Sow; S Bennett; K McAdam
Journal:  Int J Epidemiol       Date:  2005-05-24       Impact factor: 7.196

2.  Public-private mix TB activities in Meerut, Uttar Pradesh, North India: delivering dots via collaboration with private providers and non-governmental organizations.

Authors:  Shruti Sehgal; Puneet K Dewan; L S Chauhan; Suvanand Sahu; Fraser Wares; Reuben Granich
Journal:  Indian J Tuberc       Date:  2007-04

3.  Short report: Gender differences in tuberculosis notification in Pakistan.

Authors:  Andrew J Codlin; Saira Khowaja; Zhongxue Chen; Mohammad H Rahbar; Ejaz Qadeer; Ismat Ara; Joseph B McCormick; Susan P Fisher-Hoch; Aamir J Khan
Journal:  Am J Trop Med Hyg       Date:  2011-09       Impact factor: 2.345

Review 4.  Tuberculosis.

Authors:  A D Harries; C Dye
Journal:  Ann Trop Med Parasitol       Date:  2006 Jul-Sep

5.  The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi.

Authors:  Judith R Glynn; Amelia C Crampin; Malcolm D Yates; Hamidou Traore; Frank D Mwaungulu; Bagrey M Ngwira; Richard Ndlovu; Francis Drobniewski; Paul E M Fine
Journal:  J Infect Dis       Date:  2005-06-23       Impact factor: 5.226

6.  Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis.

Authors:  M Marjani; P Baghaei; P Tabarsi; M Shamaei; D Mansouri; M R Masjedi; A Velayati
Journal:  East Mediterr Health J       Date:  2012-09       Impact factor: 1.628

7.  Epidemiological aspects of human immunodeficiency virus/tuberculosis co-infection in Ribeirão Preto, Brazil from 1998 to 2003.

Authors:  Jordana Nogueira Muniz; Antonio Ruffino-Netto; Tereza Cristina Scatena Villa; Mellina Yamamura; Ricardo Arcencio; Roxana Isabel Cardozo-Gonzales
Journal:  J Bras Pneumol       Date:  2006 Nov-Dec       Impact factor: 2.624

8.  HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV.

Authors:  Pam Sonnenberg; Judith R Glynn; Katherine Fielding; Jill Murray; Peter Godfrey-Faussett; Stuart Shearer
Journal:  AIDS       Date:  2004-03-05       Impact factor: 4.177

9.  Notification of patients with tuberculosis detected in the private sector, Tehran, Iran.

Authors:  M R Masjedi; L Fadaizadeh; R Taghizadeh Asl
Journal:  Int J Tuberc Lung Dis       Date:  2007-08       Impact factor: 2.373

10.  Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil.

Authors:  Isabella Ramos de Oliveira Liberato; Maria de Fatima P Militão de Albuquerque; Antônio Roberto Leite Campelo; Heloísa Ramos Lacerda de Melo
Journal:  Rev Soc Bras Med Trop       Date:  2004-03-19       Impact factor: 1.581

View more
  4 in total

1.  Treatment outcomes of Gene Xpert positive tuberculosis patients in KwaMashu Community Health Centre, KwaZulu-Natal, South Africa: A retrospective review.

Authors:  Sarusha Pillay; Nombulelo P Magula
Journal:  S Afr J Infect Dis       Date:  2021-04-07

2.  Trend of Smear-positive Pulmonary Tuberculosis in Iran during 1995-2012: A Segmented Regression Model.

Authors:  Salman Khazaei; Mokhtar Soheilyzad; Leila Molaeipoor; Zaher Khazaei; Shahab Rezaeian; Somayeh Khazaei
Journal:  Int J Prev Med       Date:  2016-06-20

3.  Spatio-Temporal Analysis of Tuberculosis in Hamadan Province, West of Iran, from 1992 to 2013.

Authors:  Salman Khazaei; Shahrzad Nematollahi; Amin Doosti-Irani; Ali Zahiri; Arash Mofarrah-Zat; Erfan Ayubi; Elham Hooshmand; Ensiyeh Jenabi; Mohammad Saatchi
Journal:  Tanaffos       Date:  2019-01

4.  Pattern of infectious diseases in northern Iran: An approach to internal medicine management.

Authors:  Mohammad Ali Jahani; Zohreh Alinasab; Maysam Rezapour; Melodi Omrani Nava; Ghahraman Mahmoudi
Journal:  Caspian J Intern Med       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.